Antibacterial role of human alpha-defensin-3 proprotein in Klebsiella pneumoniae and Escherichia coli

LQ Zhou,ZS Gu,Y Zhang,JH Liu

DOI: https://doi.org/10.3321/j.issn:1673-8225.2007.38.045

2007-01-01

Abstract:Aim: To study the antibacterial effect of human a detensin-3 proprotein on Klebsiella pneumoniae and Escherichia coli, so as to provide references for the study on the antibacterial mechanism of defensin. Methods: The experiment was performed at Liu Jian-hua's laboratory of Life Science and Technology College, Shanghai Jiao Tong University from November 2005 to September 2006. The genes coding human α defensin-3 proprotein sequence were cloned to vector pDEST17, and the resulting vectors were transformed into E coli DE3 cells. The human a defensin-3 proproteins were obtained through induction in vitro and affinity chromatography purification. The antibacterial activity of the proprotein was analyzed according to the proportion of survived Klebsiella pneumoniae and Escherichia coli under proprotein at different concentrations and the lethal doses of a defensin-3 proproteins inducing 50%, 90% and 99% microbial lethality. Results: 1 Approximately 12 mg purified fusion proteins were obtained from 1 L culture medium with the renaturing rate of 15% to 20%. 2 The survival rates of Klebsiella pneumoniae were 50%, 33%, 10% and 4% under 5, 10, 15 and 30 mg/L proteins; the rates of Escherichia co# were 50%, 10%, 5% and 1% under 10, 20, 30 and 45 mg/L proteins. 3 The concentrations of recombinant proteins resulting in 50% and 99% microbial lethality for Klebsiella pneumoniae were 5 and 35 mg/L respectively, while those for E.coli DH5 α were 10 and 45 mg/L. Conclusion: Recombinant and purified human α defensin-3 proprotein could kill both Klebsiella pneumoniae and Escherichia coli DH5 α efficiently.